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A B S T R A C T
Rectal metastases from breast carcinomas are very rare. They often occur in lobular invasive breast carcinoma (ILC),
usually after a long disease-free period. It is important to be aware of these unusual metastatic patterns of ILC of the
breast because of the possibility of systemic therapy. We present a case of 83-year old woman with rectal metastesis from
ILC seven years after surgery of primary tumor.
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Introduction
Breast cancer is the most frequent malignancy in the
female population. According to the data from Croatian
National Cancer Registry breast cancer incidence is 95.7/
100 000, and accounts for 24% of all cancers among
women1.
Breast carcinoma usually metastasizes to lymph no-
des, lung, bone, liver or brain, and rarely to gastrointesti-
nal tract (GI)2. The most frequent organ involved in GI
tract is the stomach, followed by small intestine3–14,
while colonic and rectal metastases are extremely ra-
re15–22. Recognition of rectal metastases is important be-
cause they could easily be misdiagnosed as primary rectal
adenocarcinoma due to clinical presentation. It is also
very important to diagnose it properly because of the
therapy.
We present a case of an 83-year old woman with meta-
static lobular breast carcinoma to the rectum presenting
with obstruction. The breast tumour was diagnosed 7
years prior to the presentation of rectal metastasis.
Case Report
An 83-year old blind woman had undergone left modi-
fied radical mastectomy and axillary lymph node dissec-
tion in June 2002 due to breast carcinoma. Histopatho-
logical examination revealed a 2 cm infiltrating lobular
carcinoma of histological grade 2, with 9 from 12 resected
axillary lymph nodes infiltrated by tumour cells (pT1N2).
All 4 interpectoral Rotteri lymph nodes were also infil-
trated. Immunohistochemical analysis of oestrogen re-
ceptor showed strong nuclear positivity (100%) and anal-
ysis of progesterone receptor revealed strong nuclear
positivity (70%), while c-erbB2 was negative.
There was no evidence of distant metastasis at the
time of diagnosis. The patient received postoperative ra-
diotherapy and hormonal therapy (Nolvadex 20 mg daily
for five years).
In October 2009 the patient was admitted to hospital
because of absolute constipation for ten days. Digito-
rectal examination revealed hard thickening in more
than 2/3 circumference of the rectum, with lumen steno-
sis. This was confirmed by gastrointestinal X-ray. Endos-
copy was made and small biopsy was taken. Microscopi-
cally tumour was composed of single-file stands of infil-
trating small tumour cells with relatively little nuclear
polymorphism, loosely dispersed throughout lamina pro-
pria, with the presence of signet-ring cells. Dysplasia in
adjacent colonic epithelium was absent (Figures 1 and 2).
Tumour cells were positive for cytokeratin 7 and nega-
tive for cytokeratin 20 and E-cadherin. Immunohistoche-
719
Received for publication January 26, 2010
mical staining was positive for oestrogen receptor pro-
tein (70%) (Figure 3) and negative for progesteron recep-
tor protein as well as c-erbB2. Histological and immuno-
histochemical analysis of described tumor confirmed me-
tastasis of lobular breast cancer.
Review of slides from primary tumour and additional
immunohistochemical staining with E-cadherin (tumour
cells were negative) confirmed that primary tumour was
invasive lobular carcinoma.
Because of clinical symptoms (constipation) anorectal
amputation (Miles operation) was done. Macroscopic ex-
amination revealed rectal stenosis and slightly elevated,
whitish, hard tumour on 4 cm from annocutaneus bor-
der, infiltrating the entire rectum, measuring 7x4 cm.
Microscopically tumour was composed of single-file stands
and little clusters of infiltrating small tumour cells with
relatively little nuclear polymorphism, and with the pre-
sence of signet-ring cells. Adjacent colonic epithelium
was without signs of dysplasia or atypia. Tumour cells in-
filtrated all layers of rectum extending into pericolic fat
tissue. Four of ten lymph nodes from pericolic fat tissue
were infiltrated by tumour cells.
No other site of disease was found by abdominal com-
puted tomography, ultrasound and bone X-ray. The pa-
tient was released from the hospital 10th postoperative
day as a disease free. Treatment with anastrazole was
started three weeks after surgery. Six months after sur-
gery patient is well, without any signs of disease.
Discussion
Gastrointestinal metastases of breast cancer are rare
and usually associated with disseminated disease. Only
exceptionally are first manifestations of the disease12,13.
Metastases from breast cancer to the stomach and
small intestine have been more frequently reported3–14
compared to colonic3,6,8,15,16,21,22 and rectal involve-
ment17,18,22. Metastases to the rectum are extremely rare.
In a review of the literature, we only found two small se-
ries and a few case reports17,18,22.
Although some necroscopy studies have described an
incidence rate of colon involvement that varies from 3%
to 18% they are symptomatic in only 0.07% of cases15.
Clinical presentation of metastatic disease to the GI
tract is diverse. Symptoms may be similar to that of pri-
mary GI malignancies17, as it happened in our case or
non-specific.
The disease-free interval between primary breast can-
cer and gastrointestinal involvement is usually five to six
years, although ten or more years have rarely been
reported17,21.
Infiltrating lobular carcinoma has a particular affin-
ity for the gastrointestinal tract, with a metastasis rate
of 4.5% vs. 0.2% from infiltrating ductal carcinoma (which
involves oesophagus, stomach, small bowel, extra hepatic
bile duct)19.
Clinical and histological features which help us to dis-
tinguish gastrointestinal breast versus primary colon
cancer are: (1) absence of dysplasia in adjacent colonic
epithelium suggests a metastatic growth; (2) tumour
cells positivity for ER protein, cytokeratin 7, and nega-
tivity for cytokeratin 20 and E-cadherin; (3) history of
breast cancer. Immunohistochemistry may be very useful
in reaching the correct diagnosis. The most helpful
immunohistochemical markers are gross cystic disease
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Fig 1. Tumor cells dispersed throughout lamina propria
of colon (H&E, x40).
Fig 2. Microscopically tumor was composed of single-file stands
of infiltrating small tumor cells with the presence of signet-ring
cells (H&E, x400).
Fig 3. Immunohistochemicaly tumor cells were positive
for oestrogen receptor protein (ER, x400).
fluid protein-15 (GCDFP-15), oestrogen (ER) and proges-
terone (PgR) receptors. Metastatic breast carcinomas are
usually positive for GCDFP-15 and often for ER and/or
PgR, in contrast to most colorectal or gastric carcinomas,
which are negative23,24. Positive immunohistochemical
reaction for cytokeratin 7 and negative for E-cadherin is
suggestive for metastatic lobular carcinoma.
Endoscopy should be performed in order to accurately
detect the site of lesion. Sometimes biopsy obtained dur-
ing endoscopy will not reveal malignant cells and second
endoscopy is required. Repeated endoscopies may pre-
vent unnecessary surgical procedures.
If we consider that gastrointestinal involvement is a
sign of systemic disease, systemic therapy (chemother-
apy, endocrine treatment or both) is usually employed.
Surgery is usually necessary for an exact diagnose or for
acute clinical manifestations.
The decision-making process of whether to treat
these patients surgically should be based on the clinical
presentation and symptoms, the availability of chemo-
therapeutic options and a quality-of-life discussion25.
Patients with rectal metastases commonly present
having already developed stenosis and obstruction re-
quiring urgent correction, like in our case.
Conclusion
Rectal metastases from breast carcinomas are very
rare. Diagnosis is often difficult because of a prolonged
disease-free interval before metastatic presentation. Ne-
vertheless, in patients with lobular carcinoma this possi-
bility should be suspected in the case of symptoms sug-
gesting a rectal lesion.
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REKTALNA METASTAZA LOBULARNOG KARCINOMA DOJKE: PRIKAZ SLU^AJA
S A @ E T A K
Rektalne metastaze karcinoma dojke su vrlo rijetke. ^e{}e se javljaju kod lobularnog invazivnog kacinoma dojke,
obi~no nakon dugog perioda bez bolesti. Zbog mogu}nosti sistemske terapije, va`no je biti svjestan tog neobi~nog meta-
statskog obrasca kod invazivnog lobularnog karcinoma dojke. Prikazujemo slu~aj 83-godi{nje `ene sa rektalnom meta-
stazom lobularnog karcinoma sedam godina nakon operacije primarnog tumora.
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